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Abstract
Background: Bovine trophoblast binucleate cells (BNC) express a plethora of molecules including bovine
placental lactogen (bPL, gene name is bCSH1) and bovine prolactin-related protein-1 (bPRP1). BCSH1 and
bPRP1 are members of the growth hormone (GH)/prolactin (PRL) gene family, which are expressed
simultaneously in BNC and are central to placentation and the progression of pregnancy in cattle.
However, there is a paucity of information on the transcriptional regulatory mechanisms of both the
bCSH1 and bPRP1 genes. Recent studies, however, have demonstrated that the expression of a number of
genes is controlled by the methylation status of their promoter region. In the present study, we examined
the cell-type-specific epigenetic alterations of the 5'-flanking region of the bCSH1 and bPRP1 genes to gain
an insight into their regulatory mechanisms.
Results: Analysis of 5-aza-2'-deoxycytidine treatment demonstrated that bCSH1 expression is moderately
induced in fibroblast cultures but enhanced in BT-1 cells. Sodium bisulfite based sequencing revealed that
bCSH1 is hypomethylated in the cotyledonary tissue but not in the fetal skin, and this pattern was not
altered with the progression of pregnancy. On the other hand, the methylation status of bPRP1 was similar
between the cotyledon and fetal skin. The bPRP1 gene was exclusively hypermethylated in a bovine
trophoblast cell-derived BT-1 cell-line. While the activity of bCSH1 was similar in both BT-1 and bovine
fibroblast cells, that of bPRP1 was specific to BT-1. Treatment with a demethylating agent and luciferase
assays provided in vitro evidence of the positive regulation of bCSH1 but not bPRP1.
Conclusion: This is the first report to identify the differential regulatory mechanisms of the bCSH1 and
bPRP1 genes and indicates that bCSH1 might potentially be the only transcript that is subject to DNA
methyltransferase regulation. The data indicates the possibility of novel kinetics of induction of the
synchronously expressed BNC-specific bCSH1 and bPRP1 transcripts, which may aid the understanding of
the intricate regulation and specific role(s) of these important molecules in bovine placentogenesis and the
progression of pregnancy.
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Background
Bovine placental lactogen (bPL, gene name: bCSH1) and
bovine prolactin-related protein 1 (bPRP1) are members
of the growth hormone (GH)/prolactin (PRL) family
[1,2]. The homology between bCSH1 and bPRP1 is 62%
for nucleotides and 36% for amino acids [1]. Bovine PL is
classified as a classical member of the GH/PRL gene fam-
ily [3]. In contrast, thirteen isoforms of bPRP have been
identified and are categorized as nonclassical members of
this family [4-7]. BCSH1  has been detected in various
mammalian species including humans [1,8-13], while
orthologues of PRP1 have been detected in several ani-
mals (e.g., rodent, cattle, goats, and sheep) [2,4-7,14-16].
In the ruminant placenta, bCSH1 and bPRP1 are concur-
rently detected in trophoblastic binucleate cells (BNC)
[17,18]. The expression of both transcripts becomes
apparent in BNC from about day 20 of gestation. Coinci-
dentally, the earliest detection of the transcripts parallels
the appearance of BNC in the fetal trophoblast, and stud-
ies indicate that bCSH1 is a reliable marker of BNC mor-
phogenesis [17,18]. However, the temporal profile of
these two genes are disparate during gestation such that
the expression level of bCSH1 increases with the progres-
sion of pregnancy; whereas, the bPRP1 expression pattern
is biphasic with a gradual increase up to mid-gestation fol-
lowed by a period of steady decline [19,20]. Despite
advances in the unraveling of GH/PRL gene sequences,
structural characteristics, expression sites, and cell locali-
zation, little is known about their molecular regulatory
mechanisms in bovines. Recent studies have revealed the
transcriptional regulatory factors of the PL-family in other
species; for example, Sp1 has been identified as an impor-
tant factor for the expression of human PL; mouse PL-I has
been shown to be activated by activator protein (AP) -1,
GATA2, and GATA3; rat PL-II is reported to have binding
sites for Ets and AP-1; and ovine PL is documented to be
activated by AP-2 and GATA [21-25]. However, there is
limited information on the factors that regulate the
expression of the PRP gene, particularly in the artiodactyl
species [15,16]. Recently, we reported that the AP-2 family
may be involved in the regulation of these genes in bovine
species [26], although additional studies are necessary to
confirm this finding. However, a growing body of evi-
dence suggests that mechanisms involving epigenetic
changes regulate the expression of some genes [27-34].
Epigenetic modification involving DNA methylation has
been demonstrated to be central to tissue-dependent gene
expression, embryogenesis, and carcinogenesis [27-34].
We hypothesized that the differential expression patterns
of bCSH1 and bPRP1 are controlled by DNA methylation,
and in this study we investigated whether DNA methyla-
tion regulates the expression of the bCSH1  and
bPRP1genes in trophoblast cells.
Results
The effects of 5-aza-dC on bCSH1 and bPRP1 expression 
in cultured cells
The bCSH1 expression was moderately induced in 5-aza-
dC-supplemented fibroblast cultures (P < 0.05); whereas,
there was an increase in the overall expression intensity in
BT-1 5-aza-dC treated cultures (P < 0.05) (Figure 1A and
1B). In contrast to bCSH1,  bPRP1  expression was
decreased in BT-1 cells, but no bPRP1  expression was
detected in fibroblasts (Figure 1C and 1D).
Determination of CpG sites in the 5'-flanking region of 
bCSH1 and bPRP1
The CpG sites in the 5'-flanking region of bCSH1  and
bPRP1 were examined using Day 150 COT. In all, 19 CpG
sites were detected in bCSH1, from -4090 to the transcrip-
tion starting site, as is shown in Figure 2A. BPRP1 had 9
CpG sites from -860 to the transcription starting site, as is
shown in Figure 3A.
The DNA methylation statuses of cotyledon and fetal skin
Using samples from Day 150 COT and fetal skin (SKIN),
the DNA methylation status of the 5'-flanking region of
the bCSH1 and bPRP1 genes was examined using bisulfate
sequencing.
bCSH1
We divided the 5'-flanking region of bCSH1 into 6 regions
(region 1: -354 to -147 bp; region 2: -992 to -541 bp;
region 3: -2099 to -1651 bp; region 4: -2711 to -2300 bp;
region 5: -3428 to -3103 bp; region 6: -4094 to -3742 bp)
depending on the distribution of the CpG sites. DNA was
hypomethylated in the COT but not in the SKIN samples.
In all, 14 CpG sites (among -3343 to -215 bp) showed a
significantly low methylation status (P < 0.05). Seven of
these 14 CpG sites were assumed to be located between
regions 1 and 2 (Figure 2B).
bPRP1
We divided the 5'-flanking region of bPRP1 into 2 regions
(region 1: -495 to -75 bp; region 2: -963 to -535 bp). The
DNA methylation status was similar between the COT
and SKIN samples. Only 3 CpG sites (-470, -269 and -197
bp) in region 1 had a significantly low-level of methyla-
tion (P < 0.05) (Figure 3B).
Dynamic changes in the bCSH1 and bPRP1 gene 
methylation levels in cotyledonary tissue during gestation
bCSH1
We selected 7 CpG sites in regions 1 and 2 to compare
their methylation status during gestation (Figure 4A)
based on our findings of the CpG sites that exhibited sig-
nificantly low methylation levels in the day 150 COT sam-
ples, as shown in Figure 2.BMC Molecular Biology 2009, 10:19 http://www.biomedcentral.com/1471-2199/10/19
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On day 90 of gestation, the methylation ratios at two CpG
sites (-580 and -280) were lower (33.3%) in comparison
to the other sites (53.3% to 73.3%). These lower ratios
were maintained at the above loci throughout gestation.
However, no results were significantly different (P > 0.05).
bPRP1
We examined a total of 9 CpG sites in regions 1 and 2 dur-
ing gestation (Figure 4B). On day 60 of gestation, 7 out of
the 9 sites showed a relatively low methylation ratio (<
50%). In particular, two CpG sites (-839 and -708)
showed extremely low methylation ratios, and the
observed ratio was maintained up to day 250 of gestation
at these sites. The methylation levels increased at sites -
820 and -813 by day 150, and the hypermethylation sta-
tus was maintained up to day 250 at these sites. The meth-
ylation ratios at sites -326 and -197 decreased to half the
values observed on day 60. One specific site, -197, exhib-
ited a very low methylation ratio (only 10%) on day 250
of gestation (P < 0.05). A steady pattern of hypomethyla-
tion was observed at CpG sites -839, -780, and -708
throughout gestation.
The DNA methylation status of bCSH1 and bPRP1 in BT-
1
bCSH1
Seven CpG sites in bCSH1 regions 1 and 2 were analyzed
by sodium bisulfate sequencing using BT-1 genomic
DNA. A lower (P < 0.05) methylation ratio was found at
the -580 site in BT-1 cells compared to the levels detected
in bovine fibroblast cells (Figure 5A).
The effects of 5-aza-dC on BT-1 and endometrial fibroblast cells Figure 1
The effects of 5-aza-dC on BT-1 and endometrial fibroblast cells. The expression levels of bCSH1 (A, B) and bPRP1 (C, 
D) mRNA were determined by quantitative real-time RT-PCR. Ten μM of 5-aza-dC were added to both cell populations (A, C: 
BT-1; B, D: endometrial fibroblast cells). The expression levels were normalized to that of GAPDH mRNA. All results are dis-
played on a y-scale of 10-3, except for the insert in (B) where it is reduced to 10-5 to depict the low expression levels. Values 
are shown as the mean ± SEM, and values marked with an asterisk are significantly different (*P < 0.05).
control 5-aza-dC
10
8
6
4
2
0
*
m
R
N
A
 
q
u
a
n
t
i
t
y
 
x
 
1
0
-
3
(
b
C
S
H
1
/
G
A
P
D
H
)
(A)
control 5-aza-dC
10
8
6
4
2
0
m
R
N
A
 
q
u
a
n
t
i
t
y
 
x
 
1
0
-
3
(
b
P
R
P
1
/
G
A
P
D
H
)
(C)
control 5-aza-dC
10
8
6
4
2
0
m
R
N
A
 
q
u
a
n
t
i
t
y
 
x
 
1
0
-
3
(
b
P
R
P
1
/
G
A
P
D
H
)
(D)
control 5-aza-dC
10
8
6
4
2
0
m
R
N
A
 
q
u
a
n
t
i
t
y
 
x
 
1
0
-
3
(
b
C
S
H
1
/
G
A
P
D
H
)
(B)
*
m
R
N
A
 
q
u
a
n
t
i
t
y
 
x
 
1
0
-
5
control 5-aza-dC
20
16
12
8
4
0
*
N.D. N.D.
N.D.BMC Molecular Biology 2009, 10:19 http://www.biomedcentral.com/1471-2199/10/19
Page 4 of 14
(page number not for citation purposes)
bPRP1
Nine CpG sites in bPRP1 regions 1 and 2 were analyzed by
sodium bisulfate sequencing using BT-1 genomic DNA.
Seven of the 9 CpG sites were hypermethylated in the BT-
1 cells (more than 50%), and six out of the 9 sites were
hypermethylated in the fibroblasts. The -708, -470, and -
269 sites showed a higher (P < 0.05) methylation ratio in
the BT-1 cells than in the fibroblasts. Whereas, the meth-
ylation rate at the CpG -326 site was lower (P < 0.05) in
the BT-1 cells (Figure 5B).
The transcriptional activity in the 5'-flanking region of the 
bCSH1 and bPRP1 genes
bCSH1
The -213 bCSH1 Luc construct had the highest transcrip-
tional activity in the BT-1 (8.4 fold to the control) cells.
The -368 and -599 Luc constructs had 4.1 and 7.3 fold
higher activity relative to the no-promoter controls,
respectively. A reduction in promoter activity was noted
for the methylated -368 (P < 0.05) and -599 constructs in
the BT-1 cells. The transcriptional activity of these con-
structs in fibroblasts was comparable: the -213, -368, and
-599 constructs showed 11.8 (P < 0.05), 7.9, and 4.7 fold
activity, respectively. In contrast, methylation of the -368
(P < 0.05) and -599 constructs dramatically reduced the
promoter activity (Figure 6A and 6B) in the fibroblasts.
bPRP1
The first two fragments of the 5'-flanking region (-50 and
-80) demonstrated no transcriptional activity, in BT-1 or
fibroblast cells. The highest activity in the BT-1 cells was
found with the -277 Luc construct (13.9 fold, P < 0.05),
and increased activity was also found in the -510 (5.3
fold) and -860 (3.7 fold) constructs. Whereas, in the
fibroblasts, only the -510 construct had a higher transcrip-
tional activity than the control. Three methylated con-
structs from -277 to -860 displayed repressed
transcription in both cell populations (P < 0.05) (Figure
6C and 6D).
The detection of CpG sites and the methylation status of bCSH1 in placentomes on day 150 of gestation Figure 2
The detection of CpG sites and the methylation status of bCSH1 in placentomes on day 150 of gestation. (A) 
The location of CpG sites in the bCSH1 5'-flanking region. (B) The DNA methylation ratio of Day 150 COT (n = 3, 10 clones 
for each sample) and Day 150 SKIN samples (n = 2, 15 clones for each sample). The black bars indicate SKIN and the white 
bars depict COT samples. Values show the percentage total from 30 clones, and values marked with an asterisk(s) are signifi-
cantly different (*P < 0.05).
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Discussion
Cell to cell interactions are crucial to the development of
the placenta and the exchange of stage-specific molecular
signals between the fetal and maternal units [5,6,17,18].
Specifically, these interactions are paramount to pro-
grammed fetal growth, maternal adaptation to pregnancy,
and coordination of parturition. Trophoblast-specific
BNC is a source of an array of biochemical products
including bCSH1 and bPRP1 [17,18]. The expression pro-
files of bCSH1 and bPRP1 are dynamically distinct during
gestation, which suggests an intrinsic regulatory role in
placental formation and fetal growth in cattle [17-19].
Although, bCSH1 and bPRP1 stem from the same BNC,
the mechanism by which endogenous mediators regulate
the transcription and translation of these transcripts
remains to be established [17]. The stage-specific differen-
tial gene expression may be directly or indirectly regulated
by transcription factors [26]; however, recent studies have
established that epigenetic regulation, particularly DNA
methylation, is an important mode of control [27-34].
Here, we show evidence of epigenetic regulation of the
bCSH1 transcript in bovine trophoblasts.
Treatment of bovine fibroblasts with 5-aza-dC induced an
increase in the level of bCSH1 expression in parallel with
a decrease in the expression of bPRP1. Ectopic expression
of  bCSH1  in endometrial fibroblasts and subsequent
sequence analysis following 5-aza-dC supplementation
provided proof of the concept as well as the practicality of
the technique, as has been described for other genes [27-
34]. Interestingly, the expression of bCSH1 was restricted
to BNC and could not be induced in fibroblasts, including
The detection of CpG sites and the methylation status of bPRP1 in placentomes on day 150 of gestation Figure 3
The detection of CpG sites and the methylation status of bPRP1 in placentomes on day 150 of gestation. (A) 
The location of CpG sites in the bCSH1 5'-flanking region. (B) The DNA methylation ratio of Day 150 COT (n = 3, 10 clones 
for each sample) and Day 150 SKIN samples (n = 2, 15 clones for each sample). The black bars indicate SKIN and the white 
bars depict COT samples. Values show the percentage total from 30 clones, and values marked with an asterisk(s) are signifi-
cantly different (*P < 0.05).
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COT fibroblasts (data not shown), implying that the
source of the cells as well as the cell microenvironment
influences mRNA expression. Additionally, the impact of
the length and position of methylation zones may be
unique for each gene, and the influence of 5-aza-dC may
be quenched depending on the cell/gene milieu. In con-
trast, compelling evidence obtained over the past decade
has demonstrated that histone acetylation is linked to
transcriptional activation [30]. Studies involving the
Nanog  gene, which is a key factor in maintaining the
pluripotency of stem cells, revealed that its expression is
not affected by 5-aza-dC; however, a combination treat-
The dynamic methylation status of bCSH1 and bPRP1 in placentomes Figure 4
The dynamic methylation status of bCSH1 and bPRP1 in placentomes. (A) The dynamic DNA methylation ratios at 
each site in bCSH1. The black bar indicates Day 90 COT, the gray bar Day 150 COT, and the white bar Day 250 COT. (B) The 
dynamic DNA methylation ratios at each site in bPRP1. The black bar indicates Day 60 COT, the gray bar Day 150 COT, and 
the white bar Day 250 COT. Values show the percentage total from 30 clones (n = 3, 10 clones for each sample), and values 
marked with an asterisk(s) are significantly different (*P < 0.05).
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ment including trichostatin A facilitated expression [30].
This indicates that gene transcription is intricately regu-
lated by a functional link between DNA methylation and
histone acetylation. In this study, we did not examine the
biological role of histone acetylation in relation to bCSH1
and bPRP1 regulation, and this remains to be clarified.
Although the precise regulation of bCSH1  and  bPRP1
remains obscure, our study provides the first evidence of a
methylation-based regulatory mechanism for bovine PL-
related transcripts.
We envisioned that a number of CpG islands in the 5'-
flanking region of bCSH1 will be hypomethylated in the
COT, taking into account that the bCSH1 gene is a tro-
The DNA methylation status of bCSH1 and bPRP1 in BT-1 cells Figure 5
The DNA methylation status of bCSH1 and bPRP1 in BT-1 cells. The DNA methylation ratios of BT-1 and cotyledon-
ary fibroblast cells in (A) bCSH1 and (B) bPRP1. The black bar indicates cotyledonary fibroblast cells, and the white bar depicts 
BT-1 cells. The values show the percentage total from 30 clones, and values marked with an asterisk(s) are significantly differ-
ent (*P < 0.05).
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phoblast-specific transcript [17]. On the other hand, we
predicted that the majority of CpG sites associated with
bCSH1 in somatic cells, such as SKIN will likely be hyper-
methylated. The bisulfite sequencing confirmed the above
notion, particularly, the results from the day 150 samples
(Figure 2B). We further demonstrated that the methyla-
tion status of bPRP1 is distinct from that of bCSH1. Gen-
erally, the methylation pattern of both genes mirrored
their expression profiles throughout gestation, particu-
larly at the -197 site of bPRP1. However, it remains to be
elucidated whether the changes observed in the methyla-
tion levels of both genes are to some extent dependant on
the proportion of somatic versus trophoblast cells in pla-
centomes throughout the various stages of gestation.
Hence, it is important to delineate the stage-specific regu-
latory role of methylation patterns in relation to cell pop-
ulations to facilitate interpretations of the activation/
suppression of trophoblast-specific transcripts. On the
other hand, we only detected three CpG sites of bPRP1
that were significantly different between the COT and
SKIN samples at day 150 (Figure 3B). The biological sig-
nificance of the variation in the methylation levels
observed between the fibroblast cells and SKIN at day 150
is not clear. However, these differences could be attribut-
able to their divergent expression patterns during gesta-
tion [5]. Additionally, the evidence from in-vitro cultures
of HeLa cells indicates that the DNA methylation pattern
undulates during the cell cycle of a mature somatic cell
The transcriptional activity of bCSH1 and bPRP1 constructs in BT-1 cells and fibroblasts Figure 6
The transcriptional activity of bCSH1 and bPRP1 constructs in BT-1 cells and fibroblasts. The transcriptional activ-
ity of BT-1 cells (A, C) and bovine fibroblast cells (B, D). (A) and (B) show that of bCSH1, while (C) and (D) show that of bPRP1. 
The left figures show constructs, the horizontal lines indicate the length of the constructs, and the circles indicate the CpG 
sites. "M" and the black circles indicate methylated constructs, and "U" and white circles indicate unmethylated constructs. The 
values are shown as the mean ± SEM (n = 3), and values marked with an asterisk(s) are significantly different (*P < 0.05).
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[35]. Therefore, the likelihood of some dynamic altera-
tions in global methylation levels with progressive subcul-
tures of fibroblasts needs verification.
During gestation, bCSH1  expression continuously
increases with the progression of gestation, while bPRP1
also increases up to mid-gestation followed by a steady
decline [19,20]. The question is what controls this dispa-
rate pattern of expression of these co-expressed molecules.
Accordingly, we first confirmed the transcriptional activi-
ties of both genes and detected no marked difference in
bCSH1  activation between the BT-1 cells and bovine
fibroblast cells. Similarly, unmethylated bPRP1 constructs
retained activity in both cell lines. Notably, the levels of
bPRP1  transcriptional activity for the individual con-
structs were different between the fibroblasts and BT-1
cells. Also, the unmethylated bPRP1 constructs had lower
transcriptional activity, while the methylated constructs
augmented suppression. Although these results indicate
that the expression of both genes is affected by their meth-
ylation status, other factors may be participating in their
regulation, such as, histone acetylation or ubiquitination
and/or transcription factors [27,30,36,37]. In this study,
the efficiency of the transfection constructs in BT-1 cells
was lower than that in the fibroblast cells (data not
shown). So the efficiency of transfection may be affected
by the intensity of luciferase activity, and more effective
transfection methods need to be developed for precise
analysis of luciferase activity. The DNA sequences of the
5'-flanking region in bovine and ovine (o)CSH1  are
highly conserved, and the binding site of AP-2 was
detected in bCSH1 as a consensus cis-element that is sim-
ilar to the cis-element (-58 bp) that has been recognized
in oCSH1 [3,25,38]. Furthermore, Sp1 (-220 to -215) and
GATA (-475 to -470, and -105 to -99) consensus binding
sites exist within the -599 region, which was confirmed by
GENETYX Ver.8 (Genetyx, Tokyo, Japan). These binding
sites might interact with AP-2, as these transcriptional fac-
tors are documented to regulate some placental specific
genes [24-26,28,39-41]. To date, there are no reports con-
cerning the interplay between transcriptional factors and
bPRP1, but AP-2 may be a regulatory factor since its
expression profile in bovine placenta parallels that of
bPRP1 [26]. Ushizawa et al. [26] reported two AP-2 con-
sensus binding sites in the upstream region within -200 (-
44 to -33 and -74 to -63), but surprisingly in this study,
the constructs containing these two sites showed no tran-
scriptional activity in either the BT-1 or fibroblast cells.
Therefore, the role of the above sites in transcription reg-
ulation needs further elucidation [26]. In the present
study, we detected a new AP-2 consensus binding site (-
267 to -260) using GENETYX Ver.8, and the constructs
containing these sites, -860, -510, and -277, exhibited
high bPRP1transcriptional activity in BT-1 cells. Therefore,
it is plausible that AP-2 is involved in the transcriptional
regulation of bPRP1. Additionally, Sp1 (-270 to -265) and
GATA (-84 to -79) consensus binding sites were also
detected in the upstream region of bPRP1 by GENETYX
Ver.8 analysis. This likely denotes combinatorial regula-
tion of the transcriptional activation and/or suppression
of bPRP1.
In summary, our findings demonstrate that DNA methyl-
ation may regulate dynamic changes in gene expression
during BNC morphogenesis, placental formation, and
trophoblast differentiation in bovine species. However,
further studies are necessary to understand the precise
transcriptional regulatory mechanisms of bCSH1  and
bPRP to comprehend their role in placentogenesis,
fetogenesis, maternal recognition and adjustment to preg-
nancy, and coordination of parturition. This may also
provide an insight into the roles of the various homolo-
gous and orthologous members of the GH/PRL family
that are detected in the placenta.
Conclusion
Our data indicates for the first time that there are different
regulatory mechanisms for the bCSH1 and bPRP1 genes
and demonstrates that bCSHI may be subject to transcrip-
tional regulation by DNA methylation. These data unravel
the novel kinetics of the induction of the synchronously
expressed BNC-specific bCSH1  and  bPRP1  transcripts,
which may aid the understanding of the intricate regula-
tion and the specific role(s) of these important molecules
in bovine placentogenesis and the progression of preg-
nancy.
Methods
Animals and tissue collection
Placental cotyledonary villi (COT) and fetal skin (SKIN)
were collected from Japanese black cows. The artificial
insemination day was designated as day 0 of gestation.
The tissues collected across specific stages of gestation
were designated as follows: (i) Day 60: COT samples were
collected from three different cows on days 54, 64, and 65
of gestation (n = 3 animals for bisulfite sequencing of
bPRP1); (ii) Day 90: COT samples were collected on days
87, 88, and 97 (n = 3 animals for bisulfite sequencing of
bCSH1); (iii) Day 150: COT samples were collected on
days 144 (n = 2 animals) and 150 (n = 3 animals for
bisulfite sequencing), and SKIN samples were collected
from both animals (n = 2 animals for bisulfite sequenc-
ing) and designated as Day 150 SKIN; and (iv) Day 250:
COT samples were collected on days 245, 249, and 252 (n
= 3 animals for bisulfite sequencing). The collected sam-
ples were stored at -80°C prior to DNA extraction. All pro-
cedures for these animal experiments were carried out in
accordance with guidelines approved by the Animal Com-
mittee of Iwate University and the National Institute of
Agrobiological Sciences for the use of animals.BMC Molecular Biology 2009, 10:19 http://www.biomedcentral.com/1471-2199/10/19
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Cell culture
BT-1 cells established from in vitro blastocysts [42,43]
were cultured according to a previously described method
[44]. Briefly, the cells were cultured in Dulbecco's modi-
fied Eagle's medium/F-12 medium (DMEM/F-12, Sigma,
Saint Louis, MI, USA) containing 100 IU/ml of penicillin
and 100 μg/ml of streptomycin (Sigma) supplemented
with 10% fetal bovine serum (FBS, HANA-NESCO,
Tokyo, Japan) at 37°C in an atmosphere of 5% CO2. The
medium was changed every two or three days. A monol-
ayer of confluent BT-1 cells was mechanically passaged by
pipetting. The dissociated cell clumps in the medium were
plated on collagen-coated flasks. The cell clumps attached
themselves to the flasks and proliferated to re-form a
monolayer. Successful passages were also achieved by
transferring multicellular vesicles that had spontaneously
formed from the cell colony. Bovine endometrial or coty-
ledonary fibroblast cells, which had been derived from
the uteruses of Japanese black cattle and established as
detailed elsewhere [45], were cultured in DMEM/F-12
(sigma) containing 100 IU/ml of penicillin and 100 μg/
ml of streptomycin (Sigma) supplemented with 10% FBS
(HANA-NESCO) at 37°C in an atmosphere of 5% CO2. In
this study, 4th passaged endometrial fibroblast cells or
9th passaged cotyledonary fibroblast cells were used. The
medium was changed every two to three days. A monol-
ayer of confluent fibroblast cells was passaged and scaled
down using 0.25% Trypsin-EDTA (Sigma) and plated on
flasks.
5-aza-2'-deoxycytidine treatment
A confluence of 30–40% of bovine endometrial fibroblast
cells or cotyledonary fibroblast cells was plated on a 100-
mm dish and incubated for 24 h. Then, the cells were
treated with either vehicle or 10 μM 5-aza-2'-deoxycyti-
dine (5-aza-dC) in an FBS-containing medium for 72 h.
The medium and 5-aza-dC were changed every 24 h. The
BT-1 cells were treated as described above.
Total RNA was isolated from the cultured cells using TRI-
zol Reagent (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer's instructions. The RNA concentration
was calculated by measuring the absorbance with a spec-
trophotometer (U-2000A, HITACHI, Tokyo, Japan). All
RNA samples were stored at -80°C prior to processing.
RT-PCR
One microgram of total RNA was reverse transcribed into
cDNA with a Random Primer (TOYOBO, Osaka, Japan)
and Superscript III reverse transcriptase (Invitrogen). PCR
was performed using AmpliTaq Gold DNA polymerase
(Applied Biosystems, Foster City, CA, USA). The anneal-
ing temperature was 60°C, and the PCR involved 35
cycles. The PCR products were analyzed by agarose gel
electrophoresis and visualized by ethidium bromide
staining. The respective primer sets for bCSH1, bPRP1, and
GAPDH  are listed in Table 1. All the primers were
designed using Primer 3 [46] and commercially synthe-
sized (Greiner, Tokyo, Japan). The PCR products were
extracted from agarose gel and purified using a GENE-
CLEAN III Kit (MP Biomedicals, Solon, OH, USA). The
purified PCR products were ligated to the pGEM-T Easy
vector (Promega, Madison, WI, USA) and amplified in
DH-5α (Invitrogen). All plasmids were purified using the
QIAprep Spin Miniprep Kit (QIAGEN, Valencia, CA, USA)
and sequenced using an ABI Prism 3100 automatic
sequencer (Applied Biosystems).
Table 1: The Oligonucleotide primers used for the RT-PCR and quantitative real-time RT-PCR.
Gene Strand Sequence Position
RT-PCR
bCSH1
(NM_181007)
Forward 5'-CTGCTGGTGGTGTCAAATCTAC-3' 170–191
Reverse 5'-TGGTTGGGTTAATTGTGGGC-3' 828-812
bPRP1
(NM_174159)
Forward 5'-CACGGTCAACAGGAGTCCTCACC-3' 43–65
Reverse 5'-AATTTCAGGTAGCCCGCTGTGG-3' 873-852
GAPDH
(NM_001034034)
Forward 5'-CCTTCATTGACCTTCACTACATGGTCTA-3' 173–200
Reverse 5'-GCTGTAGCCAAATTCATTGTCGTACCA-3' 1029-1003
real-time RT-PCR
bCSH1 Forward 5'-GCAACATTGGTGGCTAGCAA-3' 281–300
Reverse 5'-GCCCTCGCCAAACTGTTTATTA-3' 358-337
bPRP1 Forward 5'-CACGGAGCTGCAGCATATGA-3' 501–520
Reverse 5'-CCTTGTGGCGCTTGATAGGA-3' 558-539
GAPDH Forward 5'-AAGGCCATCACCATCTTCCA-3' 280–299
Reverse 5'-CCACCACATACTCAGCACCAGCAT-3' 355-332BMC Molecular Biology 2009, 10:19 http://www.biomedcentral.com/1471-2199/10/19
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Quantitative real-time RT-PCR
Real-time RT-PCR was performed using the SYBR Green
Detection System (Applied Biosystems) according to the
method described previously [26]. PCR and the resulting
increase in reporter fluorescent dye emission were moni-
tored in real time using a 7300 Real Time PCR System
(Applied Biosystems). The primer pair was designed by
the Primer Express Program (Applied Biosystems). The
primers for each gene are listed in Table 1. The thermal
cycling conditions included one cycle at 50°C for 2 min,
one cycle at 95°C for 10 min, and 40 cycles at 95°C for 15
s and 60°C for 1 min. To quantify the mRNA concentra-
tions, standard curves were generated for each gene by
serial dilution of the plasmids containing their cDNA. The
expression ratio of each gene was normalized relative to
the abundance of a validated endogenous control GAPDH
mRNA to adjust for variations in the RT-PCR reaction.
Quantitation was performed using three separately cul-
tured samples per condition, and all values are presented
as mean ± SEM.
Genomic DNA extraction
The genomic DNA was extracted from COT, SKIN, and
cultured cells using a Puregene DNA Purification System
(Gentra Systems, Minnesota, U.S.A.) according to the
manufacturer's instructions. The DNA concentration was
calculated by a spectrophotometer. All DNA samples were
stored at -30°C prior to processing.
Preparing constructs for sequencing and luciferase 
reporter assays
The sequence of the 5'-flanking regions of bCSH1  and
bPRP1 was confirmed by cloning them. Each fragment of
the bCSH1 and bPRP1 regions was amplified using PCR
with primers designed on Map Viewer, which is available
on the NCBI web site [47]. Each PCR was performed using
KOD-Plus-Ver.2 (TOYOBO). The primer sets used are
listed in Tables 2 and 3. The annealing temperature was
set at 62 to 65.5°C, and the PCR lasted 30 cycles. The PCR
products were analyzed by agarose gel electrophoresis and
visualized by ethidium bromide staining. The PCR prod-
ucts were cut by Kpn I (TOYOBO) and Xho I (TOYOBO),
or Sac I (TOYOBO) and Xho I, before being cloned into
the pGL3-Basic vector (Promega) using a DNA Ligation
Kit Ver.2.1 (TaKaRa, Tokyo, Japan). All constructs were
amplified in SCS110 (Stratagene, La Jolla, CA, USA),
which lacks two methylases (dcm and dam), and
sequenced using an ABI Prism 3100 automatic sequencer
(Applied Biosystems) [30].
Sodium bisulfite genomic sequencing
CpG methylation status was examined at each stage of
gestation (Day 90 COT, Day 150 COT, Day 250 COT, and
Day 150 SKIN for bCSH1; Day 60 COT, Day 150 COT,
Day 250 COT, and Day 150 SKIN for bPRP1) as well as in
cultured cells (BT-1 and bovine fibroblast cells) by
sodium bisulfite genomic sequencing analysis. The details
of the sodium bisulfite genomic sequencing are contained
in previous reports [32,33]. Briefly, DNA (1 μg) digested
with EcoRI (for bCSH1) or BamHI (for bPRP1) was dena-
tured in 0.3 M NaOH at 37°C for 15 min. Then, 3.6 M
sodium bisulfite (pH 5.0) and 0.6 mM hydroquinone
were added, and the sample underwent 15 cycles of 30 s
denaturation at 95°C and 15 min of incubation at 50°C.
The sample was desalted using the Wizard DNA Clean-up
system (Promega) and desulfonated in 0.3 M NaOH.
DNA was ethanol precipitated and dissolved in 40 μl of
Tris-EDTA buffer. All modified DNA samples were stored
at -80°C prior to processing.
The DNA fragments were amplified with bisulfite PCR
using AmpliTaq Gold (Applied Biosystems) and the set of
primers described in Tables 4 and 5. The primer design
was performed using MethPrimer [48]. The annealing
temperature was set at 56 to 62°C, and the total number
of cycles was 35. The PCR products were analyzed by aga-
rose gel electrophoresis and visualized by ethidium bro-
mide staining. The PCR products were cloned into a
pGEM-T Easy vector (Promega). Ten clones from COT and
15 clones from SKIN for each sample and region (calcu-
lated as total 30 clones per region) were sequenced using
an ABI Prism 3100 automatic sequencer (Applied Biosys-
tems), and the methylation ratios of the samples were
determined. Thirty clones from cultured cells from each
sample and region were sequenced using an ABI Prism
3100 automatic sequencer. All results are shown as per-
centages.
Table 2: The primers used for the bCSH1 (NW_001494181) 5'-flanking region of the sequencing and reporter constructs.
Position Strand Sequence Annealing
-4090 to -4073 Forward 5'-ATGGTACCATTGTCTATTACAGGGTGCA-3' 65.5
-599 to -581 Forward 5'-GGGGTACCCCTGTCCTAGTTCTTTAAC-3' 64
-368 to -353 Forward 5'-GGGGTACCCCTTAGATCTCTGAGTAG-3' 62.6
-213 to -194 Forward 5'-GGGGTACCCCATAGGGTGTATACAGATAC-3' 62
-8 to +8 Reverse 5'-ATCTCGAGATGGGAATGCCTAAGGAG-3'
a All forward primers have a KpnI recognition site (-GGTACC-), and the reverse primer has an XhoI recognition site (-CTCGAG-) at its 5'-end. b 
The reverse primer is common to all PCRs.BMC Molecular Biology 2009, 10:19 http://www.biomedcentral.com/1471-2199/10/19
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In vitro methylation of constructs
The constructs for the luciferase reporter assay were meth-
ylated  in vitro by SssI CpG methylase (New England
BioLabs) in the presence of 160 μM of S-adenosylmethio-
nine at 37°C for 3 h [30]. Completion of the methylation
reaction was confirmed when digestion with Hha I was no
longer possible [49].
Luciferase reporter assay
The constructed plasmids with or without methylation
were transfected into BT-1 using ExGen 500 in vitro Trans-
fection Reagent (Fermentas, Hanover, USA) and bovine
fibroblast cells using FuGENE 6 (Roche Diagnostics,
Basel, Switzerland). After 10 days of passaging, the BT-1
cells were transfected with 5 μg of constructs and 50 ng of
pRL-TK (Promega), and cultured in the conditions
detailed above for 72 h. Bovine fibroblast cells were trans-
fected with 200 ng of constructs and 2 ng of pRL-TK and
cultured in the conditions described above for 48 h. The
luciferase activity was measured by a TR-717 Microplate
Luminometer (Applied Biosystems) [50]. The activity of
all constructs was determined using a Dual-Luciferase
Reporter Assay System (Promega) according to the manu-
facturer's instructions. Assays were performed three times,
and all results are shown as the mean ± SEM.
Statistic analysis
The Student's t-test and Pearson's chi-square test were
used to analyze the statistical differences between the 5-
aza-dC supplemented and non-supplemented samples
and the sodium bisulfite treated genomic sequences,
respectively. Differences among luciferase reporter con-
structs were assessed by one-way ANOVA, followed by the
Tukey-Kramer multiple comparison test. Differences were
considered significant at P < 0.05.
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